Emma Woolner

1.2k total citations · 1 hit paper
6 papers, 847 citations indexed

About

Emma Woolner is a scholar working on Infectious Diseases, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Emma Woolner has authored 6 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 2 papers in Molecular Biology and 1 paper in Cardiology and Cardiovascular Medicine. Recurrent topics in Emma Woolner's work include SARS-CoV-2 and COVID-19 Research (3 papers), Viral gastroenteritis research and epidemiology (1 paper) and Viral Infections and Immunology Research (1 paper). Emma Woolner is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), Viral gastroenteritis research and epidemiology (1 paper) and Viral Infections and Immunology Research (1 paper). Emma Woolner collaborates with scholars based in Canada, United States and China. Emma Woolner's co-authors include Matthias Götte, Danielle Porter, Calvin J. Gordon, Egor P. Tchesnokov, Jason K. Perry, Joy Y. Feng, John D. Lewis, Mark T. McDermott, Desmond Pink and Scott D. Findlay and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and ACS Sensors.

In The Last Decade

Emma Woolner

5 papers receiving 827 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency

2020 698 citations Calvin J. Gordon, Egor P. Tchesnokov et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emma Woolner Canada	4	682	207	135	107	95	6	847
Thi-Tuyet-Nhung Le France	7	610 0.9×	254 1.2×	112 0.8×	107 1.0×	40 0.4×	14	811
Naveen Vankadari Australia	10	651 1.0×	278 1.3×	119 0.9×	56 0.5×	122 1.3×	22	958
Ashleigh Shannon France	10	487 0.7×	177 0.9×	93 0.7×	74 0.7×	42 0.4×	16	673
Carina Stiller Germany	6	363 0.5×	232 1.1×	119 0.9×	47 0.4×	34 0.4×	9	643
Min-Han Lin Taiwan	10	325 0.5×	156 0.8×	91 0.7×	61 0.6×	44 0.5×	14	522
Florian Seitz Germany	6	308 0.5×	162 0.8×	68 0.5×	44 0.4×	57 0.6×	11	514
Anusuya Bhattacharyya India	13	658 1.0×	225 1.1×	218 1.6×	27 0.3×	188 2.0×	25	1.0k
Florian Kabinger Germany	3	363 0.5×	136 0.7×	76 0.6×	48 0.4×	34 0.4×	3	481
Chuanjuan Tao United States	7	377 0.6×	183 0.9×	85 0.6×	58 0.5×	36 0.4×	7	576
Robert N. Kirchdoerfer United States	7	679 1.0×	258 1.2×	168 1.2×	99 0.9×	21 0.2×	13	926

Countries citing papers authored by Emma Woolner

Since Specialization

Citations

This map shows the geographic impact of Emma Woolner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Woolner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Woolner more than expected).

Fields of papers citing papers by Emma Woolner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Woolner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Woolner. The network helps show where Emma Woolner may publish in the future.

Co-authorship network of co-authors of Emma Woolner

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Woolner. A scholar is included among the top collaborators of Emma Woolner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Woolner. Emma Woolner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Tchesnokov, Egor P., Laura J. Stevens, Tia M. Hughes, et al.. (2025). Mechanism and spectrum of inhibition of viral polymerases by 2′-deoxy-2′-β-fluoro-4′-azidocytidine or azvudine. PubMed. 2(3). ugaf029–ugaf029.

2.

Pink, Desmond, et al.. (2022). Application of Surface-Enhanced Raman Spectroscopy to Guide Therapy for Advanced Prostate Cancer Patients. ACS Sensors. 7(3). 827–838. 10 indexed citations

3.

Tchesnokov, Egor P., Calvin J. Gordon, Emma Woolner, et al.. (2021). Correction: Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action. Journal of Biological Chemistry. 297(2). 101048–101048. 2 indexed citations

4.

Gordon, Calvin J., Egor P. Tchesnokov, Emma Woolner, et al.. (2020). Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency. Journal of Biological Chemistry. 295(20). 6785–6797. 698 indexed citations breakdown →

5.

Tchesnokov, Egor P., Calvin J. Gordon, Emma Woolner, et al.. (2020). Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action. Journal of Biological Chemistry. 295(47). 16156–16165. 117 indexed citations

6.

Stoletov, Konstantin, Lian Willetts, Robert J. Paproski, et al.. (2018). Quantitative in vivo whole genome motility screen reveals novel therapeutic targets to block cancer metastasis. Nature Communications. 9(1). 2343–2343. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact